tiprankstipranks
Adial Pharmaceuticals Inc (ADIL)
NASDAQ:ADIL
US Market

Adial Pharmaceuticals (ADIL) Income Statement

Compare
503 Followers

Adial Pharmaceuticals Income Statement

Last quarter (Q4 2024), Adial Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Adial Pharmaceuticals's net income was $-2.07M. See Adial Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -564.00$ -60.50K$ -55.11K$ -564.00
Operating Expenses
$ 8.28M$ 6.89M$ 13.32M$ 17.74M$ 10.93M
Depreciation and Amortization
$ 0.00$ 564.00$ 564.00$ 55.11K$ 564.00
EBITDA
$ -8.28M$ -7.00M$ -13.32M$ -19.46M$ -10.93M
Operating Income
$ -8.28M$ -6.89M$ -13.32M$ -19.29M$ -10.93M
Other Income/Expenses
$ -4.91M$ -113.94K$ 585.21K$ -1.82M$ 34.99K
Pretax Income
$ -13.20M$ -7.00M$ -12.73M$ -19.52M$ -10.89M
Net Income
$ -13.20M$ -7.00M$ -12.73M$ -19.42M$ -10.86M
Per Share Metrics
Basic EPS
$ -0.71$ -4.92$ -11.98$ -26.12$ -21.79
Diluted EPS
$ -0.71$ -4.91$ -11.98$ -26.12$ -21.79
Weighted Average Shares Outstanding
18.59M 1.42M 1.06M 743.55K 498.52K
Weighted Average Shares Outstanding (Diluted)
18.59M 1.42M 1.06M 743.55K 498.52K
Currency in USD

Adial Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis